EKSO Insider Trading Activity and SEC Form 4 Filings
EKSO insider trading summary
Over the past 12 months, insiders at Ekso Bionics Holdings, Inc. (EKSO) reported 12 open-market purchases worth $1.2M by 3 insiders and 6 sales worth $232K by 3 insiders on SEC Form 4. Net insider buying was $972K.
Latest EKSO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 16, 2026 | Jason C Jones | Chief Operating Officer | Buy | $15K (1,308 @ $11.85) |
| Mar 16, 2026 | Jerome Wong | Chief Financial Officer | Buy | $15K (1,308 @ $11.85) |
| Feb 19, 2026 | Daniel Asher | 10% Owner | Buy | $12K (1,200 @ $9.60) |
| Feb 19, 2026 | Daniel Asher | 10% Owner | Buy | $191K (15,540 @ $12.30) |
| Feb 13, 2026 | Daniel Asher | 10% Owner | Buy | $144K (16,100 @ $8.96) |
| Feb 13, 2026 | Daniel Asher | 10% Owner | Buy | $101K (11,092 @ $9.14) |
| Feb 12, 2026 | Daniel Asher | 10% Owner | Buy | $292K (30,124 @ $9.69) |
| Feb 12, 2026 | Daniel Asher | 10% Owner | Buy | $82K (8,908 @ $9.18) |
| Feb 11, 2026 | Daniel Asher | 10% Owner | Buy | $200K (20,611 @ $9.69) |
| Feb 10, 2026 | Daniel Asher | 10% Owner | Buy | $101K (10,200 @ $9.92) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.